bromodeoxyuridine has been researched along with Rett Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kubota, T; Miyake, K; Nagai, K | 1 |
Green, SH; Kormann-Bortolotto, MH; Webb, T; Woods, CG | 1 |
2 other study(ies) available for bromodeoxyuridine and Rett Syndrome
Article | Year |
---|---|
A transcriptional repressor MeCP2 causing Rett syndrome is expressed in embryonic non-neuronal cells and controls their growth.
Topics: Animals; Blotting, Western; Bromodeoxyuridine; Cell Count; Cell Fractionation; Cell Proliferation; Cells, Cultured; Cerebral Cortex; Chromosomal Proteins, Non-Histone; DNA-Binding Proteins; Embryo, Mammalian; Gene Expression Regulation, Developmental; Glial Fibrillary Acidic Protein; Immunohistochemistry; Methyl-CpG-Binding Protein 2; Mice; Mice, Knockout; Microtubule-Associated Proteins; Neuroglia; Repressor Proteins; Rett Syndrome; RNA, Small Interfering; Time Factors | 2005 |
X-inactivation in girls with Rett syndrome.
Topics: Adolescent; Adult; Autoradiography; Azacitidine; Bromodeoxyuridine; Child; Chromosome Banding; DNA Replication; Dosage Compensation, Genetic; Female; Humans; Rett Syndrome; X Chromosome | 1992 |